NYSE:ABBV

Abbvie Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy ABBV

*Your capital is at risk

$217.07

+1.64 (+0.761%)

At Close: Jun 03, 2026

AbbVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -31.34. In total, the insiders bought 778.69K and sold 29.8M ABBV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-31.34
● Buy	778.69K shares
● Sell	29.8M shares
79% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -31.34. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	21 937 Value: $5.05M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Michael Robert A. Chief Executive Officer	CEO / President	14 452 Value: $3.31M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Michael Robert A. Chief Executive Officer	CEO / President	33 833 Value: $7.74M
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Quaggin Susan E Director	Director	68 Value: $15.5K
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	34 Value: $8K
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Rapp Edward J Director	Director	147 Value: $33.6K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Quaggin Susan E Director	Director	67 Value: $15.5K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	33 Value: $8K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Rapp Edward J Director	Director	145 Value: $33.6K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Rapp Edward J Director	Director	145 Value: $33.6K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	33 Value: $8K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Quaggin Susan E Director	Director	67 Value: $15.5K
Aug 12, 2025 Buy	Common Stock, $0.01 par value M-Exempt	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $2.32M
Aug 12, 2025 Sell	Common Stock, $0.01 par value S-Sale	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $8.41M
Aug 12, 2025 Buy	Option (Right to Buy) M-Exempt	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $2.32M
Aug 12, 2025 Buy	Option (Right to Buy) M-Exempt	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $2.32M
Aug 12, 2025 Sell	Common Stock, $0.01 par value S-Sale	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $8.41M
Aug 12, 2025 Buy	Common Stock, $0.01 par value M-Exempt	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	42 370 Value: $2.32M
Aug 05, 2025 Sell	Common Stock, $0.01 par value S-Sale	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	3 234 Value: $641.2K
Aug 05, 2025 Sell	Common Stock, $0.01 par value S-Sale	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	10 061 Value: $2.00M
Aug 05, 2025 Sell	Common Stock, $0.01 par value S-Sale	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	10 061 Value: $2.00M
Aug 05, 2025 Sell	Common Stock, $0.01 par value S-Sale	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	3 234 Value: $641.2K
Jul 01, 2025 Buy	Common stock, $0.01 par value	Crum Demetris D EVP, Chief Hr Officer	Officer	0 Value: $0
Jul 01, 2025 Buy	Option (Right to buy)	Crum Demetris D EVP, Chief Hr Officer	Officer	5 043 Value: $883.9K
Jul 01, 2025 Buy	Option (Right to buy)	Crum Demetris D EVP, Chief Hr Officer	Officer	4 687 Value: $903.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBVIE INC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...

Read Full Profile Here